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Abstract
Background: Disability Adjusted Life Years (DALYs) quantify the loss of healthy years of life due to dying prematurely
and due to living with diseases and injuries. Current methods of attributing DALYs to underlying risk factors fall short
on two main points. First, risk factor attribution methods often unjustly apply incidence-based population attributable
fractions (PAFs) to prevalence-based data. Second, it mixes two conceptually distinct approaches targeting different
goals, namely an attribution method aiming to attribute uniquely to a single cause, and an elimination method aiming
to describe a counterfactual situation without exposure. In this paper we describe dynamic modeling as an alternative,
completely counterfactual approach and compare this to the approach used in the Global Burden of Disease 2010
study (GBD2010).
Methods: Using data on smoking in the Netherlands in 2011, we demonstrate how an alternative method of risk
factor attribution using a pure counterfactual approach results in different estimates for DALYs. This alternative method
is carried out using the dynamic multistate disease table model DYNAMO-HIA. We investigate the differences between
our alternative method and the method used by the GBD2010 by doing additional analyses using data from a
synthetic population in steady state.
Results: We observed important differences between the outcomes of the two methods: in an artificial situation
where dynamics play a limited role, DALYs are a third lower as compared to those calculated with the GBD2010
method (398,000 versus 607,000 DALYs). The most important factor is newly occurring morbidity in life years gained
that is ignored in the GBD2010 approach. Age-dependent relative risks and exposures lead to additional differences
between methods as they distort the results of prevalence-based DALY calculations, but the direction and magnitude
of the distortions depend on the particular situation.
Conclusions: We argue that the GBD2010 approach is a hybrid of an attributional and counterfactual approach,
making the end result hard to understand, while dynamic modelling uses a purely counterfactual approach and thus
yields better interpretable results.
Keywords: Comorbidity, Disability weights, Incidence, Multi-morbidity, Prevalence, Risk factor attribution
* Correspondence: Hendriek.Boshuizen@rivm.nl
1National Institute for Public Health and the Environment, P.O. Box 13720 BA
Bilthoven, The Netherlands
2Wageningen University, Wageningen, The Netherlands
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Boshuizen et al. BMC Public Health  (2017) 17:197 
DOI 10.1186/s12889-017-4024-2
Introduction
In 1993, the World bank report ‘Investing in Health’ [1]
introduced the DALY as a measure for the burden of dis-
ease of a population. The DALY aims to “quantify loss of
healthy years of life due to dying prematurely or to living
with the health consequences of diseases, injuries or risk
factors” [2]. This measure is operationalized as the sum of
Years of Life Lost (YLL due to the mortality caused by a
disease, injury or risk factor and Years Lost due to Disabil-
ity (YLD) because of the disease, injury or risk factor.
DALYs were introduced to calculate the burden of dis-
eases and injuries in a population. The YLL, YLD and
DALYs of all individual diseases add to a total YLLs, YLDs
and DALYs in a population. One important methodo-
logical critique on the DALY was that it took multi-
morbidity insufficiently into account. When YLDs due to
two different diseases are added, the years with multi-
morbidity will contribute twice in the total burden in
terms of YLDs. This is only valid if the disability weights of
the two diseases can be added up, which is often not the
case. Therefore, the 2010 global burden of disease study
(GBD2010 [3, 4]) has improved the estimation of YLDs by
attributing a smaller part to each disease in order to take
this into account. This method eliminates any double
counting of years with multi-morbidity in the total burden
of disease in terms of YLDs, assuming the underlying as-
sumption of independent disease occurrence is correct.
DALYs, however, are not only calculated for assessing
the burden of diseases and injuries, but also for assessing
the burden of specific risk factors [5]. DALYs of diseases
and injuries are attributed to risk factors [5] using a coun-
terfactual approach. In such an approach the burden of
the risk factor is determined by comparing the current
situation with a counterfactual situation where the risk
factor is reduced to the minimum level. The counterfac-
tual situation is calculated by applying population attribut-
able fractions (PAFs) to the YLDs and YLLs of the diseases
caused by the risk factor exposure, where the PAF is cal-
culated from epidemiological studies. In many cases, one
risk factor influences multiple diseases. In this case the
DALYs prevented through different diseases are added up.
This attribution method for risk factors, as used for
this in the GBD2010 (and as far as we can see in the
GBD2013) is a mixture of an (using DALYs) and a coun-
terfactual (using PAFs) approach. This results in an ap-
proach that can be criticized on three points, on which
we will elaborate further in this paper: First, the PAFs
that are used are calculated based on relative risks that
apply to disease incidence, but in the PAFs are applied
as if they apply to disease prevalence. Second, newly oc-
curring morbidity in life years gained is ignored, which
should not happen in a counterfactual approach. Third,
the adjustments for multi-morbidity that were developed
in the context of estimating the burden of disease do not
work if the disease is not completely eliminated, which
is the situation in burden of risk factor calculation where
a risk factor, rather than a disease is eliminated and mul-
tiple diseases are influenced by the same risk factor.
In the Netherlands, burden of disease calculations are
part of the Public Health Status and Foresight (PHSF) re-
ports that are produced every fourth year. DALYs have
been calculated since 1997 based on the prevalence
method, and DALYs for risk factors were calculated with a
method similar to that used in the GBD2010 in the 2002
PHSF Report. However, in preparing the 2006 PHSF Re-
port, it was realized that the prevalence based method is
problematic for estimating the burden of risk factors when
using age-dependent relative risks and exposures [6].
Therefore in this and later documents [7, 8] a modelling
approach was adopted, in which a multistate disease
model is used to simulate what happens in a population
when risk factor exposure is eliminated. To determine the
burden of each risk factor in such a modelling approach, a
multistate disease model is used to simulate a population,
both “as is” (current situation) and after elimination of the
risk factor (“what if”). In the simulated population one can
observe what happens to the future years lived, both with
and without elimination of the risk factor. The burden of
the risk factor is then given by the difference.
However, when using a multistate modelling approach,
the scale of the DALYs gained differs from that of the
DALYs calculated with more conventional calculations.
The reason for this is that the DALY calculates the gain
from eliminating exposure in a single calendar year,
while such a modelling exercise calculates the effect of
eliminating exposure now and in all future years.
In order to obtain a DALY-measure on the same scale,
one should model the effect of exposure in a single cal-
endar year. This can be done by eliminating exposure
only in the current calendar year, and afterwards return-
ing it to what it would have been in the situation with-
out the elimination.
We implemented this approach in the DYNAMO-HIA
model, which is a generic software implementation of a
dynamic multistate disease model, where users enter
their own data. In this paper we compare this approach,
using smoking as an illustration, with results using the
conventional method used by the GBD2010. The aim of
this work is to determine the magnitude of the differ-
ences in the burden of a risk factor that can result from
applying different calculation methods and to obtain
insight in the causes of such differences.
Theoretical considerations on calculation methods for the
DALY
In this section we will outline the calculation of the
DALY, the conceptual problems with the method for
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attribution of the DALY to risk factors and describe the
alternative method using dynamic modelling.
Method of DALY calculation for diseases and injuries
The DALY is a measure for the burden of disease, which
aims to “quantify loss of healthy years of life due to dying
prematurely or to living with the health consequences of
diseases, injuries or risk factors” [2]. Figure 1 shows the
concept behind the DALY: the figure depicts the numbers
lived in a population with and without disease related dis-
ability (area D and H respectively). In order to calculate the
DALY, one first defines an envelope (here the thick black
line) indicating the ideal situation: a situation without any
burden of disease. In this ideal situation, the envelope
would be completely filled with healthy years. In reality,
however, there is a burden of disease, represented by the
area M (the sum of years of life lost (YLL)) and the area D
(the sum of years of life lost due to disability (YLD)). Now
the aim of calculating a DALY for a particular disease or
injurie is to attribute the areasM and D to the different dis-
eases that cause the loss of health. As every person only dies
once, the years contributed to M can be uniquely assigned
to the primary cause of death of those dying prematurely.
The GBD2010 developed a method (described in Appendix
A) to attribute the years in D uniquely to each disease.
The DALY thus is operationalized as the sum of years
of life lost (YLL) and years of life lost due to disability
(YLD), where the latter is calculated as:
YLD ¼ DW  YD;
where YD are the years that will be spend living with
disease, and DW the disability weight.
There are two ways to calculate YD. The first, named
the incidence-based method, estimates the YD by multi-
plying the incidence and the average period that an
incident case is expected to live with the disease (to which
we will further refer to as “duration of disease”). This
method was initially used [1, 9]. The second, named the
prevalence-based method, also referred to as the hybrid
method [10], assumes a stationary situation. In that case
the odds of the prevalence of the disease is equal to inci-
dence times duration. Thus, when the prevalence is not
too high, the YD can be estimated directly by using the
prevalence of the disease in the population. This method
is used in the GBD2010 and the current GBD2013. This
latter method has the advantage of not requiring data on
disease duration, which is hard to come by. Also the prob-
lem of multi-morbidity is more easily tackled.
Method of DALY calculation for risk factors
In order to attribute DALYs to risk factors, a counterfac-
tual approach based on PAFs is generally used. In a coun-
terfactual approach one calculates the reduction in the
burden of disease when exposure to a risk factor would
have been at a theoretical minimum level. The PAFs are
based on relative risks from the epidemiological literature
on the associations of the risk factor with disease inci-
dence or mortality. In the prevalence-based method, ex-
posure refers to the past exposure, as the current
prevalence of the disease is the result of past exposure of
the risk factor. In the incidence-based method, exposure
refers to the exposure that determines the incidence.
Conceptual problems with the DALY calculation method
for risk factors
In a counterfactual approach, the question is: what would
happen if a disease or risk factor exposure would be elimi-
nated? Such an counterfactual approach is conceptually
different from a attribution approach, where the goals is
to attribute each pixel in D and M in Fig. 1 uniquely to a
single risk factor. Both approaches differ in the way they
handle multi-causality. If, for instance, a disease only oc-
curs when two causes are simultaneously present, the dis-
ease can be prevented by removing one cause, but just as
well by removing the other cause. An attribution method
will attribute only part of this disease to each cause (add-
ing up to attributing the disease exactly one time in the
total of all attributions), while a counterfactual approach
will fully attribute the disease to each risk factor, because
removing each risk factor will fully remove the disease. In
other words, in this situation a counterfactual approach
will attribute the disease twice. This is the reason for the
well-known fact that PAFs can add up to more than 100%,
or, more generally, that PAFs (and thus DALYs due to risk
factors) are not additive.
In applying the PAF (representing a counterfactual ap-
proach) to disease specific DALYs (representing an attri-
bution approach), the GBD2010 method for calculating
the burden of disease due to risk factors is a mixture of
Fig. 1 Concept behind the DALY attribution. On the y-axis the
number of persons in the population that are still alive (healthy)
at a particular age when following a birth cohort over time
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two conceptually different approaches. The result is a hy-
brid method, the result of which is difficult to interpret.
There are several reasons why the method does not cor-
rectly represent the effects of elimination a risk factor
(that is, setting a risk factor at the theoretical minimum
level). The first and most important one is that with
regards to the YLL, the method assumes that all years
gained by eliminating mortality due to the risk factor will
be healthy years. It thus ignores substituting morbidity
[11]. In an attribution approach, where the goal is to attri-
bute current morbidity and mortality, this is justified, but
not in a counterfactual approach. This is because in a
counterfactual approach, the years gained by elimination
will be partly years spent in less than full health. Second,
with regards to the YLD, the GBD2010 calculation impli-
citly assumes that multi-morbidity will remain the same
after elimination of the risk factor. However, if part of the
multi-morbidity is also prevented (because diseases share
the risk factor), this is not the case and the method over-
corrects. Third, the years lived with disease (YD, that is,
the duration for a single incident case) are assumed to be
constant. However, elimination of the risk factor will de-
crease mortality from diseases that share the risk factor,
and thus YD will increase after elimination of the risk fac-
tor. This means that -in theory- risk factor elimination by
decreasing mortality could even increase the YLDs. Lastly,
as we show in Appendix A, the methods developed to take
multi-morbidity into account, do not work in case of par-
tial elimination of diseases (which is the case by elimin-
ation of one risk factor of a disease).
Another criticism on the method to calculated DALYs
for risk factors is that the PAF is applied to YLDs calcu-
lated using the prevalence method. The PAF itself, how-
ever, is calculated using relative risks derived from studies
on the association between risk factor exposure and dis-
ease incidence (or disease mortality), not prevalence.
Therefore, this PAF should only be applied to YLD from
an incidence and not a prevalence method. Applying the
PAF to YLDs based on prevalence means that the ratio of
disease prevalence in exposed and unexposed is assumed
to be the same as the ratio of disease incidence in exposed
and unexposed. In case of low prevalence and equal mor-
tality in both groups, this might be approximately true,
but only if exposure and relative risks are constant over
age. Many exposures differ in older and younger age
groups, and also relative risks generally decline with age.
In that case the PAF that should be applied to prevalence-
based YLD at a certain age group should be based on the
exposure and relative risks at lower ages, at the moment
that the disease first occurred (moment of incidence).
In summary, given a mix of a counterfactual and an at-
tribution approach, and applying incidence based rela-
tive risks to prevalence, it is not clear what exactly the
DALYs attributed to a risk factor represent.
The alternative: dynamic modelling
In dynamic modelling, the evolution of disease in a
population is simulated over time. This kind of model-
ling has been developed to perform counterfactual
(“what-if”) calculations: The amount of disease and mor-
tality in a counterfactual situation (here called a sce-
nario) can be determined simply by rerunning the
simulation under this scenario.
Figure 2 presents such a model with two diseases. In this
figure, the diseases are assumed to be irreversible, so no
remission is included. Exposure to the risk factor influ-
ences the transition rate from a state without a particular
disease to the state with a disease (the incidence rates i1
and i2, here assumed to be conditionally independent, that
is, independent within those being equal with respect to
risk factor status and presence or absence of disease). Fur-
thermore, in every state subjects can die, governed by
mortality rates mx where the mortality rate depends on
the state x (e.g. mortality is higher in those with the dis-
ease than in those without the disease). In this model, the
probability of dying does not directly depend on the ex-
posure, but does so indirectly, as exposure increases the
incidence, and mortality is higher in those with a disease.
The mortality in those without the disease is calculated
from the population all-cause mortality by subtracting
the disease-related mortality, which is calculated from
the prevalence of the disease at baseline and the
Fig. 2 A multistate disease model for two diseases sharing an
exposure. The transitions between states are governed by the
incidence rates i (here taken independent of the presence of the
other disease) and mortality rates m. In this model the exposure
changes the incidence rates
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disease related mortality. The incidence rate of an in-
dividual with a certain risk factor exposure is calcu-
lated as a baseline incidence times the relative risk
(RR) for that risk factor exposure. The relative risks
are obtained from the literature, the incidence rates
are based on data from GP or cancer registries.
Given a particular exposure, the accompanying inci-
dence rates, and the effect of exposure on the incidence
rates, the model can be used to simulate the future
health states in a population.
DYNAMO-HIA is software (downloadable from www.
Dynamo-hia.eu) simulating such a model for a single
risk factor with a particular number of diseases [12, 13].
DYNAMO-HIA simulates the development of risk factor
exposure over time using micro-simulation. Given the
simulated exposure, it calculates the incidence rates and
from that the probability of each health state over time.
Part of the incident cases can die immediately when get-
ting the disease (acute mortality).
In this model, a state is characterized by the presence or
absence of each of the diseases that are modelled. Thus
the number of states is 2N were N is the number of dis-
eases in the model, so multi-morbidity is explicitly mod-
elled. After simulating the entire future development of
disease states and death, the number of years lived within
each health state in the population can be obtained by
adding the probabilities of being in the state over all simu-
lated individuals. These years then are multiplied by the
appropriate disability weight. For each combination of dis-
eases, a disability weight is calculated using a multiplica-
tive formula, conforming to the same choice for a
multiplicative effect as was made by the GBD2010 project:
DWs ¼ 1−
Y
d
1−DWdð Þ
where d is the index for the disease, DWs the disability
weight for the health state and DWd the disability weight
for someone with disease d only.
A change in the initial risk factor exposure, as for in-
stance the complete elimination of exposure, changes
disease incidence and in turn future disease prevalence
and mortality. The gain in life years and in disability
weighted life years from such elimination can be calcu-
lated by subtracting the (disability weighted) life years in
a simulated population where the risk factor has been
eliminated from those in a simulation where the expos-
ure is equal to the observed exposure.
Such a calculation gives the gain for every person in the
population over his or her entire future lifespan. In such a
simulation one has to specify the exposure not only at the
start of simulation, but also in future life years. If exposure
is eliminated not only for the present, but also in the entire
future, the gain will be much larger than that calculated by
the DALY, that only aims to calculate the gain of eliminating
exposure in a particular calendar year. In order to obtain a
measure on the same scale as the DALY, therefore exposure
is eliminated only in the current calendar year, and after-
wards returns to what it would have been in the situation
without the elimination. This is somewhat similar to the 10-
year intervention suggested in 2003 in WHO-CHOICE’s
generalized CEA methodology (WHO 2003) [14].
Data and methods used for comparison of calculation
methods
Our objective is to compare the dynamic modelling ap-
proach with the method used by the GBD2010 in order
to obtain further insight in the magnitude of the differ-
ences between the two methods.
For illustration purposes we use smoking, in relation
to four diseases: lung cancer, Chronic Obstructive
Pulmonary Disease (COPD), Coronary Heart Disease
(CHD) and stroke.
In order to make a fair comparison, we used the same
data (incidence, mortality, relative risks etc.) in both
methods. This means that the GBD method in this paper
does not yield DALY comparable to those calculated by
the GBD project, as they use different relative risk, mortal-
ity and prevalence data. For the same reason, we use the
remaining life-expectancy for the Netherlands as calcu-
lated from the mortality rates used as basis for the YLL.
Data sources used in the DYNAMO-HIA modelling
DYNAMO-HIA requires input on 1) demography (popula-
tion numbers, all-cause mortality); 2) epidemiological infor-
mation on disease incidence, prevalence, excess mortality
(defined as the difference in mortality rate between those
with and without the disease) and acute mortality for rele-
vant diseases; 3) initial risk factor exposure and transition
probabilities for risk factor exposure (in order to simulate
future risk factor trajectories for the case with current ex-
posure), and 4) relative risks linking exposure to disease.
All these data are differentiated by age and sex.
In the illustration for this paper we used data estimates
for the Dutch population with 2011 as the calendar year to
which the calculations apply. Lung cancer incidence
(1989–2011) and survival data (1989– 2010) were available
from the Netherlands Cancer registry, and Poisson models
(including time-trends) were used to model age- and gen-
der specific incidence and excess mortality rates in 2011.
Stroke and coronary heart disease (CHD) incidence rates
were taken from the Netherlands Information Network of
General Practice (LINH) for 2011. For stroke and CHD,
patients were linked to hospital records (1995–2010) in
order to obtain only incident cases in those without pre-
vious CHD and stroke respectively, and linked to cause-of-
death records from the national mortality register in order
to include immediately fatal cases. Both prevalent and
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incident cases were linked to death records in order to ob-
tain mortality for those with disease compared to those
without the disease. For stroke and CHD, mortality was
split into short term (less than 1 year) and long term mor-
tality. Acute mortality was calculated by subtracting long-
term mortality from the observed one-year mortality.
COPD incidence data were from the same GP registration.
Again both prevalent and incident cases were linked to
death records in order to determine excess mortality rates.
Calculating death rates from differences between those
with and without the disease has the advantage of in-
cluding excess mortality where the disease is not regis-
tered as the cause of death. However, it might
overestimate mortality in case there is confounding from
risk factors (other than smoking, as that effect is ad-
justed for in our modelling). However, this potential
overestimation will not disturb our comparison of
methods, as this is used in both cases.
Although we also had current prevalence data for all
diseases, for the purpose of this exercise we want to use
a population in equilibrium, as we did not want our re-
sults to be influenced by time trends. In order to derive
input data representing a population at equilibrium, we
used the incidences and mortality rates described above
and simulated the prevalence of disease in a cohort of
newborns, who were all disease free at birth. The simu-
lated future prevalence rates in this cohort were used as
starting prevalence rates.
We used the smoking prevalence as obtained from a
2011 smoking survey from the Dutch Foundation on Smok-
ing and Health in the population aged 16 and older. Smok-
ing data comprised the proportion of current smokers,
former smokers and never smokers. Smoking rates were as-
sumed zero until and including age 10 and afterwards we
let the rates increase linearly with age towards the observed
prevalence rates at age 16. We used a multinomial spline
model (package VGAM in R) to smooth the smoking rates
over age. Again, as we want to use an equilibrium situation,
we used transition rates that keep the age- and sex specific
smoking probabilities constant over time.
We used the relative risks that were used for previous
chronic disease modelling in the Netherlands, which
smoothly change over age and are presented in Appendix
A; we considered using the GBD2010 Relative risks [15]
instead, but those are only available for smokers and non-
smokers, while we prefer to distinguish former smokers
from never smokers. Our relative risks differ by age. For
cardiovascular disease they decrease with age, as is also
the case in those used for the GBD2010 [5]. This is due to
the fact that the same absolute risk difference translates to
a lower relative risk when the baseline risk (that is, the risk
in never smokers) increases with age. For COPD and lung
cancer, the relative risks first increase with age, reflecting
higher average cumulative exposure with age, but at high
ages the effect of increasing baseline risk takes over and
relative risks decline with age [16].
In order to obtain insight in the causes of the differ-
ences between methods, we additionally performed ana-
lyses using an artificial situation (artificial data instead of
the empirical data described above) in which:
– relative risks do not depend on age (see Appendix A
for the values used)
– smoking proportions are the same for all ages, and
subjects do not change their smoking status over age
– disease prevalence rates are in equilibrium with the
mortality and incidence rates under these new
conditions
– a stable population: the age distribution is in
equilibrium with the mortality rates (under a
constant birth rate).
In this last artificial situation, the prevalence method
and incidence method are expected to deliver more or
less similar results, so the difference between the dy-
namic modeling and the GBD2010 method will not be
due to these differences.
We used the following disability weights: cancer of the
lung: 0.285; stroke 0.609, CHD 0.288 and COPD 0.314.
The values were derived assuming that the distribution
over severity states of each disease is fixed and are equal
to those used in the 2014 PHSF report [8].
In the DYNAMO-HIA model, also a disability weight is
given to those without one of the diseases in the model, as
these persons will have disabilities due to diseases that are
not modelled, or simply due to old age. We both ran the
analyses with and without these extra disability weights. In
the latter case perfect health is assumed for anyone with-
out one of the four diseases in the model.
Data manipulation for the use of data in the GBD2010-
type calculations
In order to have a fair comparison, the data used in the
GBD2010 method should be the same as those used in
the DYNAMO modelling. Below we describe how we
obtained such data.
Mortality (YLL)
Disease specific mortality in the DYNAMO model is not
obtained from statistics on cause-specific mortality, but
from the difference in mortality between those with and
without a disease (which DYNAMO-HIA names “excess
mortality”), adjusted for effects of risk-factor related
multi-morbidity from other modelled diseases [17]. In
order to use mortality rates in the GBD2010-type calcu-
lation equal to the data used in the DYNAMO-HIA
modelling, we used this attributable mortality.
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The mortality rate used was calculated as follows:
First, the attributable mortality rate in the prevalent
population was taken from the model. From this the
one-year probability of dying was calculated as 1-
exp(- ma) + i * (1-(1-exp(- ma))/ma), where i is the
incidence rate (excluding fatal cases), and ma the at-
tributable mortality rate. The last term in this expres-
sion represents the mortality from those who acquire
the disease during the simulated year, and die before
the beginning of the next year. For diseases with
acute mortality (stroke, CHD) we added the mortality
of newly diagnosed cases to this mortality rate.
As the number of life years lost for each death we took
the remaining life expectancy for that age and gender.
By doing so we deviate from the GBD2010 method,
which used a normative life table. For this exercise, how-
ever, our choice makes for a better comparison between
methods, as the same life table is used in both methods.
Prevalence (YLD)
The disease prevalence was the same as used as initial
prevalence in the DYNAMO-HIA model.
We multiplied the disease prevalence in our population
with the PAF calculated based on the relative risks and
risk factor exposure prevalence and the disability weights
as used in the DYNAMO-HIA model. The disability
weight was adjusted for multi-morbidity using the same
method as applied in the GBD2010, and described above.
However, as we only used four diseases, we could do so by
straightforward enumeration instead of simulation.
Results
Table 1 shows the YLLs calculated according to the GBD
method and based on the overall years gained by elimin-
ation the risk factor from the DYNAMO-HIA model.
The DYNAMO-HIA model is not able to attribute death
to specific causes as death, so only total years gained are
available. In the illustration case, the YLLs calculated by
dynamic modeling are smaller than those by the
GBD2010 approach. In contrast, in the artificial case
(with exposure and RRs equal for all ages), the YLLs
calculated by dynamic modeling are larger than those
calculated by the GBD2010 approach.
Overall, however, the differences between the results
from the different methods were less than 20%.
Table 2 shows the YLDs calculated with the GBD2010
method compared to the values obtained when subtract-
ing the YLLs from the dynamic modelling from the
DALY values obtained from Dynamic modeling. The
DYNAMO-HIA model does not split the disability in
those with multiple diseases in parts attributed to indi-
vidual diseases. Therefore DYNAMO-HIA is not able to
attribute YLDs to specific diseases, so only total healthy
years gained are available. Here lower “YLD” values in
Table 1 Years of Life Lost (YLL; in thousands) calculated with
the GBD2010 method and with DYNAMO-HIA. Both with realistic
data (Illustration case) and with artificial data
Disease lllustration Case Artificial dataa
Dynamic Modeling
Men 187 173
Women 138 127
GBD method
Lung cancer Men 68.7 66.7
Women 63.4 55.9
CHD Men 23.3 47.4
Women 9.1 23.3
Stroke Men 12.0 24.8
Women 8.6 22.7
COPD Men 58.8 63.1
Women 39.0 44.1
Total Men 163 202
Women 120 146
athe risk factor exposure and relative risks are the same for all ages, and the
population is stable over time
Table 2 Years Lost to Disability (YLD; in thousands) calculated
with the GBD2010 method and with DYNAMO-HIA. The latter is
calculated as DALY minus YLL. Both with realistic data (Illustration
case) and with artificial data
Illustration
Case
Artificial
dataa
Daly – Yll from Dynamic Modeling
Including DW from other diseases Men 68 51
Women 54 47
Only DW from smoking- related
diseases
Men 99 82
Women 88 80
YLD GBD2010 method
Lung cancer Men 3.5 3.8
Women 2.6 2.5
CHD Men 24.6 48.5
Women 16.9 37.2
Stroke Men 13.7 23.7
Women 9.8 22.6
COPD Men 60.7 61.0
Women 54.7 59.2
Total Men 123 137
Women 84 122
athe risk factor exposure and relative risks are the same for all ages, and the
population is stable over time
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the dynamic modelling compared to the GBD2010 ap-
proach are observed for all cases where disability from
all diseases is included in the dynamic modelling.
With a zero disability weight for the non-smoking re-
lated diseases to model the situation of less substitute
morbidity (last lines under dynamic modeling in Table 2),
the dynamic modeling “YLD” will comprises only “healthy
years gained” related to the four diseases included in the
model. Here the difference with the GBD2010 method is
considerably smaller, and for women the healthy years
gained from the dynamic approach are even slightly larger
than the YLDs calculated with the GBD2010 approach.
In the artificial case (with exposure and RR not de-
pending on age) the years gained from decreased disabil-
ity in the dynamic approach are considerably lower that
the YLDs calculated by the GBD2010 method.
Together this means that the GBD method assigned
470,000 DALYs to smoking, while the dynamic mod-
elling method yielded 447,000 DALYs, which rose to
512,000 DALYs when disability of non-smoking re-
lated diseases was ignored. Although these final fig-
ures are rather similar, the artificial calculations show
that these figures hide larger but opposing differences
that partially cancel each other out. In the artificial
data the GBD method assigned 607,000 DALYs to
smoking, and the dynamic modelling 398,000, rising
to 462,000 when disability of diseases not related to
smoking was ignored.
Discussion
Our case study shows that the DALY calculated with
conventional methods overestimate the gain that can be
obtained by eliminating exposure to a risk factor. There
are several explanations behind this.
First, the GBD2010 methods assumes that all years
saved by eliminating mortality will be completely healthy
years, while in the dynamic modeling approach they will
be partly years lived with disability.
This is seen most clearly when in the dynamic model-
ling DALY weights are used not only for the four dis-
eases explicitly modeled, but also for all other (not risk
factor related) diseases (Table 2).
A second explanation is that age-varying risk fac-
tor exposure or relative risks also lead to fairly large
discrepancies between results using the GBD2010
method and dynamic modelling with DYNAMO-
HIA. This is shown most clearly by comparing the
calculations with age-constant exposure and relative
risks (artificial data, Tables 1 and 2). The GBD2010
method uses relative risks, smoking prevalence and
the population numbers at a particular age a to cal-
culate the eliminated mortality at age a. In contrast,
in the dynamic modeling the mortality at age a is
influenced by relative risks and exposure at younger
ages. As we used relative risks as well as smoking
rates that decline mostly at higher ages (Appendix
A), this results in a higher YLL for the dynamic
modelling approach.
We expect these differences will also show when an
incidence-based method would be employed for DALY
calculations (also eliminating exposure effects on new
cases only) instead of a prevalence based method, elim-
inating future effects of current exposure rather than
current effects of past exposure.
However, a more fundamental problem is that the
GBD2010 method is a mixture of two conceptually
different approaches. The DALYs for diseases in the
GBD2010 clearly implements an attribution approach,
aimed at unique attribution of DALYs to diseases. In the
attribution of risk factors, however, this is mixed with a
counterfactual approach. The result is a hybrid method,
the result of which is difficult to interpret.
We propose a consistent counterfactual approach
for estimating the burden of disease of risk factors.
In this proposed approach, a multistate disease
model is used to calculate the health gains of elimin-
ating exposure in a single year. The advantage is
that it is conceptually clear what is calculated. In
order to deliver numbers pertaining to a single cal-
endar year, we propose to eliminate the exposure
only in that particular calendar year, and afterwards
return the exposure to what it would have been
without the elimination.
The dynamic modelling approach with DYNAMO-
HIA depends on assumptions: Incidence and mortality
rates are assumed to be stationary; duration of sur-
vival in those with the disease is assumed not to de-
pend on risk factor exposure; eliminating exposure is
assumed to immediately reduce the risk; and it is
assumed that the dose response function between
exposure and disease incidence can be described per-
fectly by a relative risk. This will make the modelling
only a crude approximation of reality. The modelling
therefore is not suitable for delivering predictions of
future health, but is meant as a method for “what-if”
calculation, in this case: what if exposure would be
eliminated? As similar assumptions are made in the
GBD project, we do not believe these assumptions
make our method less reliable than those calculations.
In DYNAMO-HIA we do not model phases and se-
quelae of each disease separately, but apply the same
disability weight to everyone with the disease. In
principle, however, dynamic modelling could be ex-
tended to including disease stages.
In the GBD2010, the incidence method of calculat-
ing DALYs from earlier GBDs was replaced by a
prevalence-based -or better: hybrid [10] – method.
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This made it possible to refine the YLD calculations
with co-morbidity adjustments that make this method
into a consistent attribution methodology. One of the
virtues of the prevalence-based DALY is its simplicity:
it only takes estimates of prevalence and mortality to
enable a reasonable estimate of the burden of disease.
Dynamic modelling is more complex and requires
more data and knowledge. For looking at risk factors,
however, the simplicity of the GBD method comes
with the price that it is not completely clear what en-
tity is calculated.
In GBDs before the GBD2010, the incidence-based
method was used, and a choice between attribution
or counterfactual approach was less clearly made. The
use of population attributable (or preventable) frac-
tions is much more natural with the incidence-based
method, as the relative risks on which the preventable
fractions are based are almost exclusively taken from
studies on incidence (or mortality) of disease. The
reason that incidence is generally the preferred out-
come to study as an effect of risk factor exposure is
because causality can be more easily assumed in case
of incidence. For instance, an observed relation be-
tween obesity and prevalent osteoarthritis can also be
explained by “reverse causality”, that is, pain from
osteoarthritis promotes a sedentary life style which
leads to obesity.
Applying a relative risk for incidence to prevalence
needs justification. One justification could be that
with low prevalence rates and when disease-related
mortality rates are independent of the risk factor, the
prevalence ratio will be approximately equal to the
incidence rate ratio. However, this assumes that ex-
posure is constant over time, and relative risks are
not age dependent. Our calculations showed that
when this is not the case, effects on the result are
not negligible. Lette et al. [18] give a method translat-
ing incidence-based relative risks into prevalence
ratios, but this method has not been used in the con-
text of prevalence-based DALYs.
It is often stated that “without discounting or age
weighting, incident and prevalent YLD for a disease
should be equal if there have been no past trends in
incidence, mortality or remission” [2]. However, this
is incomplete, as there also should be a stationary
population in terms of size and age structure. More-
over, it does not apply when calculating the burden
of disease from risk factors: in that case the require-
ment is also that there should be no time trends or
age-related trends in exposure and relative risks. In
most cases this is unrealistic.
When using age-constant relative risks and expos-
ure, we see lower YLLs in the dynamic modeling
(Table 1). This difference is caused by the built-in
delay time between incidence of disease and mortality
from that disease. This delay originates from the fact
that exposure influences only disease incidence dir-
ectly. Mortality is only increased after the prevalence
of the disease has increased. Here one might argue
that this effect is an artefact of the assumptions build
into the model. However, such a delay is not unrealis-
tic, and therefore constitutes a less strong assumption
than assuming no delay.
Although the YLL from the dynamic modelling
approach is higher than that obtained with the
GBD2010 approach, the DALYs are lower. An import-
ant reason is that the life years gained in our model
are not assumed to be all healthy years, but are part
of the simulated population, and thus partly spend
with (new) disease. This means that in a counterfac-
tual approach the YLLs are only partly healthy years.
From a more conceptual point of view, one could
argue that this is because in the counterfactual ap-
proach one considers the gain in the neighbourhood
of the current situation, while the attribution ap-
proach contrasts the current situation with an ideal
situation where all diseases have been eliminated.
In the GBD2010 method, the magnitude of the
YLLs is for an important part determined by the
choice of the envelope used to determine how long
someone saved from death still has to live. This
choice is arbitrary. A different choice will influence
the DALYs of risk factors associated with lethal dis-
eases proportionally more than those that mostly
cause disability. For comparison reasons we used a
country-specific envelope, narrower than that used in
the GBD. Using the GBD envelope would have made
the overestimation due to the assumption that all life
years gained are healthy years even larger. An advan-
tage of a true counterfactual approach is that it is no
longer necessary to define a mortality envelope, as
the gain in life years is automatically calculated based
on the current mortality rates and the mortality rates
after elimination of the risk factor.
Although different methods give different results,
one could ask whether this is of practical relevance
in comparative studies, especially as the expertise
and data resources needed to prepare input data for
dynamic models might not be universally available.
Although methods might deliver different absolute
numbers, they could still yield similar rankings be-
tween countries or risk factors. Things as increase of
relative risks, incidence and mortality with age are
universal, and therefore their influence on the rank-
ing of results between countries might be limited.
On the other hand, when there are clear survival
differences between countries (leading to a different
composition of the prevalent cases in terms of
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disease duration), or differences in the distribution
of exposure over age groups, or where populations
have a different age-structure, the ranking might be
affected. Also risk factors differ with regards to
which age groups are mostly exposed, so there is
clear potential for interference with rankings, espe-
cially where estimates are not too far apart.
In summary, we argued that the dynamic modelling
approach follows a clear conceptual approach and
thus is easier to understand in terms of what is being
calculated. Also aspects as multi-morbidity and sub-
stitution of morbidity and mortality are automatically
incorporated. As one strives to more accurate meth-
odology, we believe use of such models is indicated
rather than devising ever more sophisticated adjust-
ment methods for DALY calculations.
Appendix A
Consequence of applying the GBD2010 method for
multi-morbidity adjustment in risk factor elimination
In this appendix we will work out the GBD2010 method
for multi-morbidity adjustment for two diseases A and
B, and show that this adjustment delivers the correct
amount of eliminated disability weighted years when
both diseases are completely eliminated, but not in most
other cases where a disease is only partially eliminated.
Let the unadjusted disability weights for the dis-
eases A and B be equal to DWA and DWB respect-
ively, and the weight adjusted according to the
GBD2010 methodology be DWAadj and DWBadj. The
unadjusted weights are valid for someone with only
disease A (or only disease B), while the adjusted
weights are those applied in the end to every person
with disease A (or B).
In order to simplify the equations, we introduce the
“ability weights” AX = 1-DWX with X = A or B.
The GBD2010 (as well as the DYNAMO-HIA model) uses
a multiplicative model for determining the disability weights
in case of multi-morbidity, which implies that the ability
weight for someone with both disease A and B is equal to
the product of the abilities for disease A and disease B:
AAB ¼ AAAB
This assumption of multiplicativeness is only an as-
sumption, and other assumptions are possible. However,
this falls outside the scope of this paper.
In case of 2 diseases, the ability in the population is:
AA p Að Þ−p A∩Bð Þ½  þ AB p Bð Þ−p A∩Bð Þ½ 
þ AAABp A∩Bð Þ
Where p(A) and p(B) represent the prevalence of dis-
ease A and B respectively and p(A ∩ B) the prevalence of
having both disease A and B.
In the case that the prevalence of A and B are
independent (thus p(A ∩ B) = p(A)p(B)), this is equal
to:
AAp Að Þ þ ABp Bð Þ− AA þ AB−AAABð Þp Að Þp Bð Þ
The adjustment carried out by the GBD splits up the
last term up in two parts which are incorporated into AA
and AB respectively, yielding an adjusted version of AA
and AB in such a way that
AAp Að Þ þ ABp Bð Þ− AA þ AB−AAABð Þp Að Þp Bð Þ
¼ AAadjp Að Þ þ ABadjp Bð Þ ð1Þ
There are multiple ways to split-up the last term into
two parts. The GBD has chosen to split up the weight 1-
AAAB for someone with both diseases in proportion to
DWA and DWB. For the argument here, however, the
way of splitting is not relevant.
Now assume that a fraction x of disease A is elimi-
nated, and a fraction y of disease B. In our applica-
tion (elimination of risk factors) these fractions are
the preventable (or population attributable) fractions
(PARs).
The ability in the population after elimination is
equal to:
1−xð ÞAAp Að Þ þ 1−yð ÞABp Bð Þ− 1−xð Þ 1−yð Þ
AA þ AB−AAABð Þp Að Þp Bð Þ
ð2Þ
In the methodology of the GBD2010 the adjusted
version of the (dis)ability weight is applied to this case
also, thus the ability after elimination of the risk factor
according to the GBD2010 method is equal to:
1−xð ÞAAadjp Að Þ þ 1−yð ÞABadjp Bð Þ
where AA_adj and AB_adj have the same adjusted value as
are used for calculating the disease YLDs. In order for
this method to work, this should be equal to [2].
Slightly rearranging this equality and equation [1],
this means that in order for the GBD2010 method to
work, the following two equations should be valid
simultaneously:
AA−AAadj
 
p Að Þ þ AB−ABadj
 
p Bð Þ
¼ AA þ AB−AAABð Þp Að Þp Bð Þ
1−xð Þ AA−AAadj
 
p Að Þ þ 1−yð Þ AB−ABadj
 
p Bð Þ
¼ 1−xð Þ 1−yð Þ AA þ AB−AAABð Þp Að Þp Bð Þ ð3Þ
and thus
x AA−AAadj
 
p Að Þ þ y AB−ABadj
 
p Bð Þ
¼ xþ y−xyð Þ AA þ AB−AAABð Þp Að Þp Bð Þ
For each chosen value of x there is only a single
value of y for which this equation will hold, for all
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other values of y the adjustment will not yield the
right result. As y and x are given by the PAF for risk
factor elimination, it is unlikely that they will satisfy
this condition.
Note that the method will work for complete elimin-
ation of both diseases (x = y = 1), but not for complete
elimination of only one disease (e.g. x = 1 and y = 0), or
partial elimination of a disease.
Also note that the GBD method above is based on the
assumption that the probability of each disease is inde-
pendent. However, in calculating a PAF, the diseases will
share a risk factor, and because of this they will be
dependent.
Tables 3 to 5 in Appendix A illustrate the theory above
with a simple numerical example. In this example we take
a population of 10,000 persons (of the same age and gen-
der) and let disease A and B both have a prevalence of
10% (=1000 persons), and a disability weight of 0.3.
When both diseases are completely eliminated,
we eliminate 1000 cases of disease A and 1000
cases of disease B, both having an adjusted DALY
weight of 0.2955 (Table 1 in Appendix A). So we
eliminate 2 times 295.5 is 591 YLDs. This is exactly
equal to using the method that writes out the dis-
ability per group (Table 1 in Appendix A, column
“Disability weighted N”). When one disease is elim-
inated (Table 2 in Appendix A), or the two diseases
are partly eliminated (Table 3 in Appendix A), the
adjusted method delivers a lower remaining disabil-
ity in the population (as both diseases are present
before elimination), and thus a higher estimate of
the potential gain. The example also shows that
under these conditions, both the effect of the
adjustment, and the errors made in the adjustment
are small.
Appendix B
Input data of the model
Relative risks used
Figure 3 in Appendix B gives the age-depend
relative risks used in the calculations. When con-
stant relative risks were used, we used for current
smokers the RR from the GBD2013 for lung cancer
(22.51 and 14.10 for men and women respectively)
and for COPD (11.44 and 15.24 for men and
women respectively), while for former smokers we
arbitrarily took 7 and 4 for lung cancer and 10 for
COPD (for both sexes). For CHD and stroke we
used the same RRs in both sexes: 3.5 for current
smokers and 1.5 for former smokers for CHD and
2.5 (current smokers) and 1.2 (former smokers) for
stroke.
Table 3 Simple example: Situation in the population without
any elimination
N in
Population
Disability
weight
Disability
Weighted
N
Adjusted
Disability
weight
Adjusted
Disability
weighted N
Healthy 8,100 0 0 0 0
Disease A
only
900 0.3 270 0.29551) 265.95
Disease B
only
900 0.3 270 0.29551) 265.95
Both
disease A
and B
100 0.51 51 0.5912) 59.1
Total 10,000 591 591
1)(0.51/2 *100 + 0.3*900)/100 = 0.2955
2)0.2955*2
Table 4 Simple example: population after elimination of disease
A only
N in
Population
Disability
weight
Disability
Weighted
N
Adjusted
Disability
Weight
Adjusted
Disability
weighted N
Healthy 9,000 0 0 0 0
Disease
A only
0 0.3 0 0.2955 0
Disease
B only
1,000 0.3 300 0.2955 295.5
Both
disease
A and B
0 0.51 0 0.591 0
Total 10,000 300 295.5
Table 5 Simple example: population after elimination of 50% of
disease A and 50% of disease B
N in
Population
Disability
weight
Disability
Weighted
N
Adjusted
Disability
Weight
Adjusted
Disability
weighted N
Healthy 9,025 0 0 0 0
Disease
A only
475 0.3 142.5 0.2955 140.3625
Disease
B only
475 0.3 142.5 0.2955 140.3625
Both
disease
A and B
25 0.51 12.75 0.591 14.775
Total 10,000 297.75 295.5
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Smoking rates
Figure 4 Appendix B presents the age-dependent smok-
ing rates used in our realistic simulation.
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Fig. 3 age dependent relative risks used in the simulation for smokers and former smokers in men and women. Blue =males, pink = females; full
line: current smokers, dashed line: former smokers
Fig. 4 Percentage smokers and former smokers in Dutch men and
women used in the realistic simulation. Blue =males, pink = females;
full line: percentage current smokers, dashed line: percentage
former smokers
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